J Cancer
2022; 13(8):2413.
doi:10.7150/jca.73345 This issue
Erratum
Overexpression of TC2N is associated with poor prognosis in gastric cancer: Erratum
Jianbo Xu1✉*, Xinde Ou1,3*, Jin li2,3, Qinbo Cai1,3, Kaiyu Sun1, Jingning Ye1, Jianjun Peng1
1. Department of Gastrointestinal Surgery, the First Affiliated Hospital, Sun Yat-sen University, 58 Zhongshan 2nd Road, Guangzhou 510080, China.
2. Digestive Disease Center, the Seventh Affiliated Hospital, Sun Yat-sen University, 628 Zhenyuan Road, Shenzhen 518000, China.
3. Laboratory of General Surgery, the First Affiliated Hospital, Sun Yat-sen University, 58 Zhongshan 2nd Road, Guangzhou 510080, China.
*These authors contributed equally to this work.
This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Citation:
Xu J, Ou X, li J, Cai Q, Sun K, Ye J, Peng J. Overexpression of TC2N is associated with poor prognosis in gastric cancer: Erratum.
J Cancer 2022; 13(8):2413. doi:10.7150/jca.73345. Available from
https://www.jcancer.org/v13p2413.htm
Corrected-article in J Cancer, Volume 12, 807